Ádám Barsi Artúr Beke Beatrix Sármán
10.3389/fendo.2022.964481
Front Endocrinol (Lausanne)
2022 Sep 15;13:964481.
case report endogenous hyperinsulinemic hypoglycemia nesidioblastosis octreotide pregnancy
CC BY
https://pubmed.ncbi.nlm.nih.gov/36187120/
Congenital Hyperinsulinism / complications Congenital Hyperinsulinism / drug therapy Somatostatin / therapeutic use
Congenital Hyperinsulinism / complications Congenital Hyperinsulinism / drug therapy Somatostatin / therapeutic use Case Reports Adult Blood Glucose Blood Glucose Self-Monitoring Cesarean Section Child Diazoxide / therapeutic use Female Humans Hypoglycemic Agents Infant Infant, Newborn Octreotide / therapeutic use Pregnancy Pregnancy Outcome Blood Glucose Hypoglycemic Agents Somatostatin Diazoxide Octreotide
PMC9522520
36187120
Case report: A particularly rare case of endogenous hyperinsulinemic hypoglycemia complicated with pregnancy treated with short-acting somatostatin analog injections
2022